Page last updated: 2024-08-18

4-butyrolactone and Esophageal Neoplasms

4-butyrolactone has been researched along with Esophageal Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amano, Y; Fukuhara, H; Ishihara, S; Ishimura, N; Kinoshita, Y; Mishima, Y; Sanchez-Siles, AA; Takahashi, Y; Tamagawa, Y; Uno, G; Yuki, T	1
Aziz, RM; Carlton, PS; Chen, T; Dixit, R; Qin, H; Rose, ME; Stoner, GD	1

Other Studies

2 other study(ies) available for 4-butyrolactone and Esophageal Neoplasms

Article	Year
Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis. Journal of clinical gastroenterology, 2011, Volume: 45, Issue:8 Topics: 4-Butyrolactone; Adenocarcinoma; Aged; Antigens, CD34; Apoptosis; Barrett Esophagus; Bile Acids and Salts; Biopsy; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Chi-Square Distribution; Cyclooxygenase 2; Disease Progression; Enzyme Inhibitors; Esophageal Neoplasms; Esophagoscopy; Fatty Acid Synthase, Type I; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Hydrogen-Ion Concentration; Immunohistochemistry; Japan; Logistic Models; Male; Middle Aged; Odds Ratio; Precancerous Conditions; Proliferating Cell Nuclear Antigen; Risk Assessment; Risk Factors; RNA, Messenger; Time Factors	2011
The effects of L-748706, a selective cyclooxygenase-2 inhibitor, on N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis. Carcinogenesis, 2005, Volume: 26, Issue:9 Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carcinogens; Carcinoma, Squamous Cell; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dimethylnitrosamine; Dinoprostone; Esophageal Neoplasms; Gene Expression Regulation, Enzymologic; Male; Piroxicam; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred F344; RNA, Messenger; Sulfones	2005

Article

Year

Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.

Journal of clinical gastroenterology, 2011, Volume: 45, Issue:8

Topics: 4-Butyrolactone; Adenocarcinoma; Aged; Antigens, CD34; Apoptosis; Barrett Esophagus; Bile Acids and Salts; Biopsy; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Chi-Square Distribution; Cyclooxygenase 2; Disease Progression; Enzyme Inhibitors; Esophageal Neoplasms; Esophagoscopy; Fatty Acid Synthase, Type I; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Hydrogen-Ion Concentration; Immunohistochemistry; Japan; Logistic Models; Male; Middle Aged; Odds Ratio; Precancerous Conditions; Proliferating Cell Nuclear Antigen; Risk Assessment; Risk Factors; RNA, Messenger; Time Factors

2011

The effects of L-748706, a selective cyclooxygenase-2 inhibitor, on N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis.

Carcinogenesis, 2005, Volume: 26, Issue:9

Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carcinogens; Carcinoma, Squamous Cell; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dimethylnitrosamine; Dinoprostone; Esophageal Neoplasms; Gene Expression Regulation, Enzymologic; Male; Piroxicam; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred F344; RNA, Messenger; Sulfones

2005